Biolevate lands €30M Series A to scale life sciences AI
Life sciences AI company Biolevate hasraised €30 million in Series A funding to expand its platform for automatingscientific and regulatory workflows and support its international growth. Theround was...
Read the full story at Tech.eu ↗
Timeline · 2 reports
- 2026-09-22 09:08 · The Next Web
Biolevate raises €30M Series A and opens Boston office for its life sciences AI - 2026-09-22 07:50 · Tech.eu
Biolevate lands €30M Series A to scale life sciences AI